Cargando…
Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
Antiapoptotic B-cell lymphoma 2 (Bcl-2) targets the inositol 1,4,5-trisphosphate receptor (IP(3)R) via its BH4 domain, thereby suppressing IP(3)R Ca(2+)-flux properties and protecting against Ca(2+)-dependent apoptosis. Here, we directly compared IP(3)R inhibition by BH4-Bcl-2 and BH4-Bcl-Xl. In con...
Autores principales: | Monaco, G, Decrock, E, Akl, H, Ponsaerts, R, Vervliet, T, Luyten, T, De Maeyer, M, Missiaen, L, Distelhorst, C W, De Smedt, H, Parys, J B, Leybaert, L, Bultynck, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263504/ https://www.ncbi.nlm.nih.gov/pubmed/21818117 http://dx.doi.org/10.1038/cdd.2011.97 |
Ejemplares similares
-
IP(3)R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP(3)R-derived peptide targeting the BH4 domain of Bcl-2
por: Akl, H, et al.
Publicado: (2013) -
Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP(3) Receptor
por: Monaco, Giovanni, et al.
Publicado: (2013) -
Ryanodine receptors are targeted by anti-apoptotic Bcl-X(L) involving its BH4 domain and Lys87 from its BH3 domain
por: Vervliet, Tim, et al.
Publicado: (2015) -
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
por: Vervliet, Tim, et al.
Publicado: (2018) -
Bax Inhibitor-1 is a novel IP(3) receptor-interacting and -sensitizing protein
por: Kiviluoto, S, et al.
Publicado: (2012)